Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

83.3%

-3.2% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

2(50.0%)

Phase 2

1(25.0%)

Phase 3

1(25.0%)

4Total

N/A(2)

Phase 2(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT07311174Not ApplicableCompleted

Can Psychodrama Improve Aggressive Behavior and Social Adaptation in Adolescent Boys?

Role: lead

NCT06112886Completed

Identification of Important Symptoms and Diagnostic Hypothyroidism Patients Using Machine Learning Algorithms

Role: lead

NCT05402826Not ApplicableCompleted

Effect of Oral Zinc and Vitamin E Supplementation on Short-term Postoperative Outcomes in Cardiac Surgery Patients.

Role: collaborator

NCT04340128Phase 3Completed

Efficacy of Intra-lesional Injections of Glucantime Once a Week or Twice a Week in the Treatment of Anthroponotic Cutaneous Leishmaniasis (ACL)

Role: collaborator

NCT02601924Phase 2Completed

Efficacy of Pressure Massage and Topical Gel on Pain During Intra Oral Injections

Role: collaborator

NCT02146846Terminated

Population Pharmacokinetics of Imatinib in CML Patients in Iran

Role: lead

All 6 trials loaded